The Kimmel Cancer Center (KCC) Administration serves to meet the operational and financial needs of the Center, providing cost-effective management and helping to ensure that the goals of the Center are realized. Administration provides key support to the Center Director and Senior Leaders, the Programs and Shared Resources, the Executive Committee, the internal Basic Science and Clinical Science Advisory Committees, and the External Scientific Advisory Committee. KCC Administration participates in the planning and implementation of all activities throughout the programs and shared resources of the Center. Overall responsibility for the operation of Administration lies with the Executive Director, Richard L. Davidson, Ph.D., who has over 35 years'experience in the administration and management of large-scale academic units. Dr. Davidson also serves as Associate Director for Shared Resources, overseeing the activities of all the KCC shared resources. The administrative team under Dr. Davidson includes individuals for financial analysis and management, for liaison and integration with the clinical research enterprise, and for clerical assistance. Administration serves as the link between the Center and the University and Hospital offices for administration, financial affairs, space management, maintenance, construction, human resources, intellectual property, information technology, and legal counsel. The major activities of Administration involve the following areas;1) financial management of all CCSG accounts 2) operational and financial management of the shared resources;3) space management, maintenance, and renovation;4) strategic planning activities;5) Center retreats, symposia, seminars, and meetings;6) clinical trials activities;7) KCC Grand Rounds;8) faculty recruitment;9) human resources;10) educational and training programs;and 11) planning for and preparation of CCSG submissions.
Cancer Center Administration is responsible for taking care of the operational and financial needs of the Center. Administration supports all the other components of the Cancer Center Support Grant. It also serves as the link between the Cancer Center and a number of offices within the University.
|Li, Jifen; Gao, Erhe; Vite, Alexia et al. (2015) Alpha-catenins control cardiomyocyte proliferation by regulating Yap activity. Circ Res 116:70-9|
|Basile, Kevin J; Le, Kaitlyn; Hartsough, Edward J et al. (2014) Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitors. Pigment Cell Melanoma Res 27:479-84|
|Sonar, Mahesh V; Wampole, Matthew E; Jin, Yuan-Yuan et al. (2014) Fluorescence detection of KRAS2 mRNA hybridization in lung cancer cells with PNA-peptides containing an internal thiazole orange. Bioconjug Chem 25:1697-708|
|Gu, Lei; Talati, Pooja; Vogiatzi, Paraskevi et al. (2014) Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation. Mol Cancer Ther 13:1246-58|
|Bhardwaj, Anshul; Casjens, Sherwood R; Cingolani, Gino (2014) Exploring the atomic structure and conformational flexibility of a 320?Å long engineered viral fiber using X-ray crystallography. Acta Crystallogr D Biol Crystallogr 70:342-53|
|Siciliano, Nicholas A; Hersperger, Adam R; Lacuanan, Aimee M et al. (2014) Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses. J Virol 88:10078-91|
|Clark, Peter M; Loher, Phillipe; Quann, Kevin et al. (2014) Argonaute CLIP-Seq reveals miRNA targetome diversity across tissue types. Sci Rep 4:5947|
|Li, Yuan; Liang, Chunli; Ma, Haizhong et al. (2014) miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer. Molecules 19:7122-37|
|Wilson, Chantell; Lin, Jieru E; Li, Peng et al. (2014) The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer. Cancer Epidemiol Biomarkers Prev 23:2328-37|
|Khasnis, Mukta; Nakatomi, Akiko; Gumpper, Kristyn et al. (2014) Reconstituted human myosin light chain phosphatase reveals distinct roles of two inhibitory phosphorylation sites of the regulatory subunit, MYPT1. Biochemistry 53:2701-9|
Showing the most recent 10 out of 343 publications